“…For example, whereas tetraspanins CD9 and CD82 are potential metastasis suppressors (Boucheix et al, 2001;Lazo, 2007;Liu and Zhang, 2006;Tonoli and Barrett, 2005), tetraspanin CD151 has been linked to enhanced metastasis of colon, prostate and lung cancer (Ang et al, 2004;Hashida et al, 2003;Tokuhara et al, 2001). The mechanisms whereby tetraspanins might regulate metastasis can be grouped into several classes, including regulation of (i) pericellular matrix proteolysis (Gesierich et al, 2006;Hasegawa et al, 2007;Hong et al, 2006;Hong et al, 2005;Huang et al, 2007;Saito et al, 2006;Sugiura and Berditchevski, 1999), (ii) integrin cell-surface expression and trafficking (Berditchevski and Odintsova, 2007;Liu et al, 2007;Winterwood et al, 2006), (iii) integrin-dependent migration, invasion and signaling (Berditchevski, 2001;Hemler, 2005), (iv) integrin crosstalk with growth factor receptors (Sridhar and Miranti, 2006) and (v) pathological angiogenesis (Gesierich et al, 2006;Takeda et al, 2007). Most of these proposed tetraspanin functions center around regulation of cell-extracellular matrix interactions and downstream signaling events.…”